CASI(Delisted)
CASI Pharmaceuticals·NASDAQ
--
--(--)
CASI fundamentals
CASI Pharmaceuticals (CASI) released its earnings on Nov 14, 2025: revenue was 3.08M (YoY -60.54%), beat estimates; EPS was -0.68 (YoY -23.64%), missed estimates.
Revenue / YoY
3.08M
-60.54%
EPS / YoY
-0.68
-23.64%
Report date
Nov 14, 2025
EPS
Actual | -0.9 | -0.9 | -1.4 | -1.2 | -1.1 | -0.5 | -0.7 | -0.4 | -0.6 | -0.56 | -0.38 | -1.47 | -0.45 | -0.77 | -0.35 | -0.45 | -0.71 | -0.52 | -0.55 | -0.75 | -0.69 | -0.86 | -0.68 | ||||||||||
Forecast | -1.1 | -0.8 | -0.55 | -0.7 | -0.6 | -0.725 | -0.55 | -0.5667 | -0.8667 | -0.63 | -0.4567 | -0.13 | -0.64 | -0.5 | -0.56 | -0.24 | -0.05 | -0.63 | -0.62 | -0.6 | -0.61 | -0.47 | -0.4 | ||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +18.18% | -12.50% | -154.55% | -71.43% | -83.33% | +31.03% | -27.27% | +29.42% | +30.77% | +11.11% | +16.79% | -1030.77% | +29.69% | -54.00% | +37.50% | -87.50% | -1320.00% | +17.46% | +11.29% | -25.00% | -13.11% | -82.98% | -70.00% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.41M | 2.67M | 4.24M | 4.82M | 5.74M | 7.16M | 8.11M | 9.16M | 9.06M | 8.57M | 10.21M | 15.27M | 8.35M | 9.82M | 8.84M | 6.87M | 3.41M | 3.98M | 7.79M | 13.36M | 6.24M | 4.17M | 3.08M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 788.00K | 3.75M | 3.44M | 4.57M | 5.05M | 6.02M | 7.53M | 9.08M | 9.24M | 7.87M | 9.91M | 14.23M | 9.10M | 10.09M | 10.43M | 9.41M | 12.00M | 4.43M | 4.56M | 7.39M | 6.10M | 6.28M | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +332.23% | -28.77% | +23.21% | +5.60% | +13.58% | +18.94% | +7.79% | +0.89% | -1.96% | +8.91% | +3.05% | +7.29% | -8.27% | -2.68% | -15.25% | -27.02% | -71.59% | -10.20% | +70.90% | +80.63% | +2.30% | -33.47% | 0.00% |
Earnings Call
No Data
You can ask Aime
No Data
